Characterisation of oral and i.v. glucose handling in truncally vagotomised subjects with pyloroplasty
Open Access
- 1 August 2013
- journal article
- research article
- Published by Oxford University Press (OUP) in Acta Endocrinologica
- Vol. 169 (2), 187-201
- https://doi.org/10.1530/eje-13-0264
Abstract
Objective: Glucagon-like peptide 1 (GLP1) is rapidly inactivated by dipeptidyl peptidase 4 (DPP4), but may interact with vagal neurons at its site of secretion. We investigated the role of vagal innervation for handling of oral and i.v. glucose.Design and methods: Truncally vagotomised subjects (n=16) and matched controls (n=10) underwent 50 g-oral glucose tolerance test (OGTT)±vildagliptin, a DPP4 inhibitor (DPP4i) and isoglycaemic i.v. glucose infusion (IIGI), copying the OGTT without DPP4i.Results: Isoglycaemia was obtained with 25±2 g glucose in vagotomised subjects and 18±2 g in controls (POGTT−glucoseIIGI/glucoseOGTT)) – was reduced in the vagotomised compared with the control group. Peak intact GLP1 concentrations were higher in the vagotomised group. Gastric emptying was faster in vagotomised subjects after OGTT and was unaffected by DPP4i. The early glucose-dependent insulinotropic polypeptide response was higher in vagotomised subjects. Despite this, the incretin effect was equal in both groups. DPP4i enhanced insulin secretion in controls, but had no effect in the vagotomised subjects. Controls suppressed glucagon concentrations similarly, irrespective of the route of glucose administration, whereas vagotomised subjects showed suppression only during IIGI and exhibited hyperglucagonaemia following OGTT. DPP4i further suppressed glucagon secretion in controls and tended to normalise glucagon responses in vagotomised subjects.Conclusions: GIGD is diminished, but the incretin effect is unaffected in vagotomised subjects despite higher GLP1 levels. This, together with the small effect of DPP4i, is compatible with the notion that part of the physiological effects of GLP1 involves vagal transmission.Keywords
This publication has 74 references indexed in Scilit:
- Glucose-Dependent Insulinotropic PolypeptideDiabetes, 2011
- Gastric Bypass Surgery Enhances Glucagon-Like Peptide 1–Stimulated Postprandial Insulin Secretion in HumansDiabetes, 2011
- Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of TherapyDiabetes Care, 2009
- Intrameal Hepatic Portal and Intraperitoneal Infusions of Glucagon-Like Peptide-1 Reduce Spontaneous Meal Size in the Rat via Different MechanismsEndocrinology, 2008
- Sensory nerves contribute to insulin secretion by glucagon-like peptide-1 in miceAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2004
- The hepatic vagal nerve is receptive to incretin hormone glucagon-like peptide-l, but not to glucose-dependent insulinotropic polypeptide, in the portal veinJournal of the Autonomic Nervous System, 1996
- Emptying of the gastric substitute, glucagon-like peptide-1 (GLP-1), and reactive hypoglycemia after total gastrectomyDigestive Diseases and Sciences, 1991
- Preserved incretin effect after complete surgical denervation of the pancreas in young pigsZeitschrift für Die Gesamte Experimentelle Medizin, 1985
- Behavioral effects of vagotomy in humansJournal of the Autonomic Nervous System, 1983
- Glucose turnover and insulin secretion in dogs with pancreatic allograftsDiabetologia, 1970